MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1751-2980.12125

Медицинская библиотека · Journal of digestive diseases · 2014

Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.

Sherman Michael, Tsynman Donald N, Kim Albert, Arora Jyoti, Pietras Timothy, Messing Susan, St Hilaire Lydia, Yoon Sonia, Decross Arthur, Shah Ashok, Saubermann Lawrence

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

The aim of this study was to determine whether the effects of prolonged therapy (≥1 year) with anti-tumor necrosis factor (TNF) agents were sustained on the health-related quality of life (HRQoL) in patients with inflammatory bowel disease (IBD).

METHODS

A cross-sectional survey of patients with IBD who were treated with anti-TNF agents was performed. Results of the validated HRQoL measures (inflammatory bowel disease questionnaire [IBDQ], EuroQoL-5 dimensions [EQ-5D], health status visual analogue scale [VAS] and the Zung self-rating depression scale) were recorded and compared between patients treated with anti-TNF agents for <1 year and ≥1 year.

RESULTS

A total of 41 patients were finally enrolled in the study. Among them, 11 (26.8%) had received anti-TNF therapy for less than one year with a median duration of 7 months (range 3-11 months), while the other 30 (73.2%) had been treated for ≥1 year with a median duration of 42 months (range 12-104 months). Crohn's disease was the most common type in both groups. None of the mean IBDQ, EQ-5D and EQ-5D plus VAS, or Zung self-rating depression scale scores differed significantly between the two groups of patients.

CONCLUSIONS

Improvements in HRQoL for IBD patients on anti-TNF therapy were sustained for longer than one year. HRQoL measures for IBD patients treated with anti-TNF therapy for <1 year do not differ significantly from those treated for ≥1 year, but a trend towards improved HRQoL measures with prolonged therapy can be obtained.

Для цитирования: Sherman Michael, Tsynman Donald N, Kim Albert, Arora Jyoti, Pietras Timothy, Messing Susan, St Hilaire Lydia, Yoon Sonia, Decross Arthur, Shah Ashok, Saubermann Lawrence. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.. Journal of digestive diseases. 2014. DOI: 10.1111/1751-2980.12125.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.